Prevalence of thyroid autoimmunity and effect of levothyroxine treatment in a cohort of 1064 patients with recurrent pregnancy loss
ABSTRACT RESEARCH QUESTION Does initiating levothyroxine treatment based on Thyroid Stimulating Hormone (TSH) > 2.5 mIU/L or thyroid autoimmunity improve pregnancy continuation rates in recurrent pregnancy loss (RPL) patients? DESIGN We conducted a retrospective cohort study of 1064 RPL patients. Subjects were classified as either euthyroid (TSH 0.1 - ≤ 2.5 mIU/L), borderline-subclinical hypothyroid (borderline-SCH, TSH 2.5 – ≤ 4 ... Read more